Rejuvendus Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2021)
- Profit -14.41%
(FY 2021)
- Ebitda -14.41%
(FY 2021)
- Net Worth -0.95%
(FY 2021)
- Total Assets -0.07%
(FY 2021)
About Rejuvendus Clinical Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anupam Gaur, Vikas Prakash, and Neera Sharma serve as directors at the Company.
- CIN/LLPIN
U24232DL2006PTC155302
- Company No.
155302
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Nov 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rejuvendus Clinical Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anupam Gaur  | Director | 08-Nov-2006 | Current |
| Vikas Prakash | Director | 08-Nov-2006 | Current |
| Neera Sharma | Director | 20-Jan-2010 | Current |
Financial Performance of Rejuvendus Clinical Research.
Rejuvendus Clinical Research Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 14.41% decrease in profit. The company's net worth dipped by a decrease of 0.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rejuvendus Clinical Research?
In 2021, Rejuvendus Clinical Research had a promoter holding of 67.00% and a public holding of 33.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pushtinandaja Healthcare Private LimitedInactive For E-Filing 7 months 24 daysAnupam Gaur and Neera Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rejuvendus Clinical Research?
Unlock and access historical data on people associated with Rejuvendus Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rejuvendus Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rejuvendus Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
